Traded Apr 1 · filed 3 days later
Routine share withholding; mechanical by default.
Traded Mar 9, 2026 · Filed Mar 11, 2026
ADMA Biologics's COO and SVP, Compliance sold $158K of ADMA Biologics shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$157,800
Shares × reported transaction price
12 days after results of Feb 25, 2026, 58 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.1% | −2.2% | −2.9% |
| 30 days | −38.1% | +0.5% | −38.6% |
| 90 days | −48.2% | +9.0% | −57.2% |
| 180 days | −39.1% | +13.3% | −52.4% |
Past results only. Not a forecast.
Traded Apr 1 · filed 3 days later
Routine share withholding; mechanical by default.
Traded Mar 13 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Traded Mar 17 · filed 1 day later
Gift or transfer — classified separately from trades.